Scientists report that they have identified a cellular mechanism that prevents the immune system from destroying chronic, incurable viral infections such as herpes, hepatitis and human immunodeficiency virus (HIV). The research, published in the March issue of Immunity, explains why critical immune cells fail to act against the viral infection and demonstrates a successful intervention that facilitates elimination of the virus. The results open up exciting new avenues for design of future antiviral therapeutics.

Many human viruses are able to evade the immune system during acute infection and establish long-term persistent infections that are extremely difficult to eliminate. Most of the time, proliferation of the virus is balanced by antiviral immunity and the host experiences little to no damage. However, persistent infections with viruses such as HIV or hepatitis lead to life threatening diseases that currently have no cure.

Immune cells called CD8+ T cells are critical for recovery from viral infections and persistent viral infections are associated with a malfunction of these cells that is not well understood. Dr. Kim J. Hasenkrug from the Rocky Mountain Laboratories, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, and colleagues investigated persistent infection of mice with Friend virus (FV) to look at the specific mechanisms that contribute to CD8+ T cell dysfunction. The researchers found that although the CD8+ T cells could recognize their appropriate targets they could not destroy them. The key finding was that regulatory CD4+ T cells suppress the normal function of the CD8+ T cells in the persistently infected mice. Importantly, suppressing the activity of the regulatory CD4+ cells could prevent dysfunction of CD8+ T cells.

The researchers conclude that CD4+ T cells contribute to viral persistence by suppressing the host CD8+ T cell response and that influencing the activ
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
16-Mar-2004

Page: 1 2
Related medicine news :

1. Adaptive optics technology provides powerful tools for eye doctors
2. AstraZeneca submits regulatory application in Europe for use of Atacand(R) in heart failure
3. Emory scientists contribute to study of key regulatory protein in neurodegeneration
4. FDA, drug industry and scholars find success in effort to tackle regulatory issues
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. Suppressing the cells that trigger cat allergy
7. Indiana University researchers closer to helping hearing-impaired using stem cells
8. Some brain cells change channels to fine-tune the message
9. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
10. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
11. Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells